Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Pharma Intelligence is a leader in the field of healthcare industry information.
…
continue reading
Deep Pharma Intelligence (DPI) is a leading strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, BioTech, and Healthcare Tech industries. DPI is producing regular analytical reports on major areas of high-potential in the pharmaceutical and healthcare industries, maintaining ratings of companies and governments based on their innovation potential and business activity in the BioTech space, and providing strategic consulting and investment intell ...
…
continue reading
Quick Listen: Scrip's Five Must-Know Thingshttps://scrip.pharmaintelligence.informa.com/SC148456/Quick-Listen-Scrips-Five-MustKnow-ThingsPharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


1
Drug Fix: Big Pharma’s US FDA Scorecard, Sarepta’s DMD Gene Therapy Delay, US FDA Adcomm Reforms
42:12
Pink Sheet reporters and editors discuss the largest pharma companies’ pending applications (0:41), the FDA delaying its decision on Sarepta’s gene therapy in Duchenne muscular dystrophy (14:32), and a plan to add more temporary members to agency advisory committees (24:55) … as well as a little bit of “The Simpsons.”Read More In The Pink SheetEver…
…
continue reading
P
Pharma Intelligence Podcasts


1
What You Need To Know About HRA/Perrigo’s Historic US OTC Pill Switch With HBW’s Malcolm Spicer
32:56
HBW Insight catches up with our own US Executive Editor, Malcolm Spicer, to find out all about Perrigo subsidiary HRA Pharma’s Rx-to-OTC switch of its daily contraceptive, Opill. Currently under consideration by the US Food and Drug Administration after a positive recommendation from its advisory committees, Spicer draws on 30+ years of writing abo…
…
continue reading
Quick Listen: Scrip's Five Must-Know Thingshttps://scrip.pharmaintelligence.informa.com/SC148417/Quick-Listen-Scrips-Five-MustKnow-ThingsPharma Intelligence
…
continue reading
Brian Yang and Dexter Yan discuss the latest China biotech trends and topics including recent mega-million deals between domestic biotechs and MNCs, the inaugural Asia Bio Partnering Forum and drug makers’ creative ways to financing amid lingering “capital winter”, and GLP-1 receptor agonists stepping into the spotlight and its potential to become …
…
continue reading
P
Pharma Intelligence Podcasts


In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb discusses how two medtech CEOs are and aren’t using ChatGPT in their businesses while Reed Miller talks about his “Cardio Conversations” podcast interviews with Quentin Blackford, CEO of iRhythm and Rob Krummen, CEO of Vektor Medical. Washington, DC-based reporter Hannah Daniel r…
…
continue reading
Quick Listen: Scrip's Five Must-Know Things:https://scrip.pharmaintelligence.informa.com/SC148375/Quick-Listen-Scrips-Five-MustKnow-ThingsPharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


Quentin Blackford, CEO of iRhythm, talked to Medtech Insight about his company’s plans to bring its Zio long-term cardiac monitoring platform to more patients by building its evidence base and marketing in more countries outside the US.For more information on iRhythm, cardiac monitoring and ECG technologies, check out these articles at Medtech Insi…
…
continue reading
스크립의 박재홍 동아ST R&D 총괄 부문 사장 인터뷰 기사를 요약한 내용입니다https://scrip.pharmaintelligence.informa.com/SC148059/Dong-A-ST-Faces-New-Wave-Of-Change-As-It-Challenges-NormsPharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


1
Progressing The Global Self-Care Industry’s Sustainability Agenda With GSCF’s Padmaja Kamath
26:18
In this episode, HBW Insight speaks to the Global Self-Care Federation’s director of regulatory and scientific affairs, Padmaja Kamath, about the organisation’s sustainability work. In 2019, GSCF published its Global Charter for Environmental Sustainability, which represented, Kamath notes, the global consumer healthcare industry’s “first commitmen…
…
continue reading
Quick Listen: Scrip's Five Must-Know Things:https://scrip.pharmaintelligence.informa.com/SC148335/Quick-Listen-Scrips-Five-MustKnow-ThingsPharma Intelligence
…
continue reading
Scrip senior writer Joseph Haas overviews biopharma deal-making in 2022 and discusses the Pfizer/Seagen merger and what that may mean for pharma M&A during the remainder of 2023, with EF Hutton analyst Mike King and Mintz attorney Matt Gardella.Pharma Intelligence
…
continue reading
Joshua Sabari, MD Lung Cancer Specialist Answers Questions on Treating Patients with ES-SCLCPharma Intelligence
…
continue reading
Maximizing The UK Medtech Opportunity In Times Of Change by Pharma IntelligencePharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


In this episode of Medtech Connect, Medtech Insight senior regulatory writer Eliza Slawther interviews MedTech Europe’s digital lead Alexander Olbrechts about the interplay between EU medical device laws with proposed horizontal regulations that impact digital devices, such as the AI Act, the Data Act and the European Health Data Space. The importa…
…
continue reading
Quick Listen: Scrip's Five Must-Know Things:https://scrip.pharmaintelligence.informa.com/SC148297/Quick-Listen-Scrips-Five-MustKnow-Things?utm_source=sfmc&utm_medium=email&utm_campaign=Scrip%20Weekly%20EmailPharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


In this episode, HBW Insight catches up with Bayer Consumer Health’s Daniella Foster. Foster leads on the company’s public affairs and sustainability work, and so updates us on Bayer’s progress towards its net zero goals and also its Nutrient Gap Initiative, which aims to expand access to vitamins and minerals for 50 million people in underserved c…
…
continue reading
Quick Listen: Scrip's Five Must-Know Thingshttps://scrip.pharmaintelligence.informa.com/SC148258/Quick-Listen-Scrips-Five-MustKnow-ThingsPharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


1
Drug Fix: Sarepta DMD Gene Therapy Issues, New COVID-19 Vaccine Schedule, Medicare Price Negotiation
33:45
Pink Sheet reporters and editors discuss questions about Sarepta’s Duchenne muscular dystrophy gene therapy candidate (0:32), the US FDA’s efforts to simplify the COVID-19 vaccine schedule (13:15), and industry’s ideas for Medicare price negotiation system changes (24:18).Read More In The Pink SheetCBER Director Marks’ Intervention On Sarepta Gene …
…
continue reading
CNS analysts discuss neurodegenerative disorders - Parkinson’s and Alzheimer’s diseaseAlzheimer’s Disease Forecasthttps://service.datamonitorhealthcare.com/hkc/disease/central-nervous-system/neurology/alzheimers-disease/forecast/article155358.eceAlzheimer’s Disease Analysis Reporthttps://service.datamonitorhealthcare.com/hkc/disease/central-nervous…
…
continue reading
Huahui Health CSO Li Wenhui sits down with Scrip in the office to discuss many of the key issues such as, how he views antivirals development post-COVID? how the company’s hepatitis drugs differentiated from others? Given the current antivirals from Gilead among others, why Li believed that the antiviral development remains vital?…
…
continue reading
HPV vaccines have come a long way since they were first introduced in 2006, though not without their share of bumps and misinformation campaigns. Dr Kenneth Alexander, chief, Division of Infectious Diseases and Vice-Chair for Research at Nemours Children’s Hospital-Florida, talks to Scrip about various facets along this journey and more including h…
…
continue reading
P
Pharma Intelligence Podcasts


世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら(複数)「FDA's Woodcock To Supreme Court: Mifepristone Ruling Will Create 'Significant Chaos’(邦題意訳:FDA幹部、最高裁のミフェプリストン審議で「深刻な混乱」を危惧)」https://pink.pharmaintelligence.informa.com/PS148056/FDAs-Woodcock-To-Supreme-Court-Mifepristone-Ruling-Wi…
…
continue reading
Brian Yang and Dexter discuss Chinese biotech going overseas, new personal data overseas transfer standard contract, post-COVID vaccine development and CDE’s new trends.Pharma Intelligence
…
continue reading
Quick Listen: Scrip's Five Must-Know Thingshttps://scrip.pharmaintelligence.informa.com/SC148184/Quick-Listen-Scrips-Five-MustKnow-ThingsPharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


Rob Krummen, the CEO of Vektor Medical, talked to Medtech Insight about Vektor’s vMap computational modeling system that relies on 12-lead electrocardiography data to identify unstable cardiac rhythms. Further ReadingFor more information on leadless Vektor Medical, atrial fibrillation and ECG technologies addressed in this interview, check out thes…
…
continue reading
The 31st annual Pharma R&D Review.Pharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


The 31st annual Pharma R&D Review.Pharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


The 31st annual Pharma R&D Review.Pharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


The 31st annual Pharma R&D Review.Pharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


The 31st annual Pharma R&D Review.Pharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


The 31st annual Pharma R&D Review.Pharma Intelligence
…
continue reading
The 31st annual Pharma R&D Review.Pharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


The 31st annual Pharma R&D Review.Pharma Intelligence
…
continue reading
The 31st annual Pharma R&D Review.Pharma Intelligence
…
continue reading
Michael Dickinson, MD, FACC, FHFSA - board-certified Cardiologist and Heart Failure Specialist answers questions on initiating GDMT-4 and reducing HF hospitalizations.Pharma Intelligence
…
continue reading
An introduction to Ian Lloyd, author of the 31st annual Pharma R&D Review.Pharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb discusses conference highlights from SXSW and LSI while Barnaby Pickering talks about his coverage on voice biomarkers. Hannah Daniel discusses BetterHelp’s return of $7.8m to customers to settle with FTC for sharing health data.Listen to the podcast via the player below:Medtech …
…
continue reading
Quick Listen: Scrip's Five Must-Know Things:https://scrip.pharmaintelligence.informa.com/SC148184/Quick-Listen-Scrips-Five-MustKnow-ThingsPharma Intelligence
…
continue reading
In this episode of Medtech Connect, Medtech Insight regulatory reporter Hannah Daniel interviews, Kelliann Payne, partner at Hogan Lovells. Payne advises artificial intelligence (AI) medical device manufacturers with premarket submissions and helps them navigate the complicated regulatory landscape. She laid out the current FDA regulations for AI m…
…
continue reading
P
Pharma Intelligence Podcasts


A Man On Fire Fueled By A Mission To Find A Drug For Every Disease. by Pharma IntelligencePharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


1
Veristat: Advancing Revolutionary Therapies (ART): Orphan Drug Designations and Orphan Subsets
9:11
Find out more now about US FDA’s Orphan Drug Designation (ODD) program, which qualifies sponsors for incentives including tax credits, exemption from user fees, and more. Learn more about which orphan subsets could qualify for ODD, in your free podcast episodePharma Intelligence
…
continue reading
최근 스위스 바젤에서 열린 바이오 유럽 스프링 행사를 취재한 Scrip Intelligence기사를 요약한 내용입니다.https://scrip.pharmaintelligence.informa.com/SC148077/Pharma-Giants-Urge-Biotechs-To-Get-In-Touch-As-Early-As-PossiblePharma Intelligence
…
continue reading
Quick Listen: Scrip's Five Must-Know Things:https://scrip.pharmaintelligence.informa.com/SC148150/Quick-Listen-Scrips-Five-MustKnow-ThingsPharma Intelligence
…
continue reading
P
Pharma Intelligence Podcasts


1
Drug Fix: BrainStorm’s ALS Adcomm, Batch Testing Imported Drugs, US FDA’s First In-Person Meeting
29:24
Pink Sheet reporters and editors discuss the FDA’s upcoming advisory committee meeting for the controversial ALS cell therapy NurOwn, a proposal to batch test all drugs coming into the US amid problems conducting foreign inspections, and the FDA’s return to in-person meetings with industry.More On These Topics From The Pink Sheet:https://pink.pharm…
…
continue reading
DMHC analysts discuss presentations from the Advanced Therapies conferenceSupporting linksCell and Gene Therapy Podcasthttps://www.biomedtracker.com/reportdetail.cfm?reportid=1683Editing The Future Reporthttps://www.biomedtracker.com/reportdetail.cfm?reportid=1608Peripheral T-Cell Lymphoma (PTCL) Market Spotlighthttps://www.biomedtracker.com/report…
…
continue reading
P
Pharma Intelligence Podcasts


In this special podcast from Medtech Insight, editor Reed Miller talked to Andrie Leday, the US vice president for ambulatory surgery centers (ASCs) at Johnson & Johnson/DePuy Synthes. Leday's group is dedicated to creating a new "ecosystem" around DePuy Synthes broad range of orthopedic implants and tools to meet the demand of an aging population.…
…
continue reading
Quick Listen: Scrip's Five Must-Know Thingshttps://scrip.pharmaintelligence.informa.com/SC148112/Quick-Listen-Scrips-Five-MustKnow-ThingsPharma Intelligence
…
continue reading